A number of studies have initially focused on the mutational load of the tumor as well as on quality of the cells infiltrating the tumor microenvironment, and revealed that increased mutational burden and the presence of CD8+ T cells with stem-like qualities4,5, among others, can predict the response to ICI6–10. The gene discussed is CD8A; the disease is neoplasm.